AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28906355 — intervention group
Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 72
Study 26003782 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin and clopidogrel 75mg/d
Number of subjects: 52
Study 26003782 — intervention group
Group type: COMPARATOR
Intervention: Aspirin monotherapy
Number of subjects: 52
Study 26003782 — intervention group
Group type: EXPERIMENTAL
Intervention: ADP-induced aggregation <50%
Number of subjects: 52
Study 23093541 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg prednisone over 5 days
Number of subjects: 96
Study 23093541 — intervention group
Group type: COMPARATOR
Intervention: Placebo over 5 days
Number of subjects: 96
Study 21641867 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oxaliplatin and fluoropyrimidine combination chemotherapy (arm A)
Number of subjects: 1630
Study 21641867 — intervention group
Group type: COMPARATOR
Intervention: Intermittent chemotherapy (arm C)
Number of subjects: 1630
Study 21641867 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous chemotherapy (arm A)
Number of subjects: 1630
Study 19564220 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertive Community Treatment (ACT)
Number of subjects: 251
Study 19564220 — intervention group
Group type: COMPARATOR
Intervention: Usual Care from Community Mental Health Teams (CMHTs)
Number of subjects: 251
Study 16254730 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant therapy
Number of subjects: 13
Study 14698365 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 10 microg/kg IV before skin incision (Group P)
Number of subjects: 84
Study 14698365 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 10 microg/kg IV after skin incision (Group A)
Number of subjects: 84
Study 14698365 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 84
Study 10996442 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (2mg)
Number of subjects: 11
Study 10996442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 9493662 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathepsin G-like activities
Number of subjects: 38
Study 9493662 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptase-like activities
Number of subjects: 38
Study 9493662 — intervention group
Group type: COMPARATOR
Intervention: Plasmin-like activities
Number of subjects: 38
Study 8790615 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported cataract diagnosis
Number of subjects: 22071
Study 3594105 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine and phentolamine (30 mg papaverine and 1 mg phentolamine, 2 ml injection)
Number of subjects: 18
Study 3594105 — intervention group
Group type: COMPARATOR
Intervention: Saline (2 ml injection)
Number of subjects: 18
Study 31793041 — intervention group
Group type: EXPERIMENTAL
Intervention: MAL-photodynamic therapy (MAL-PDT)
Number of subjects: 0
Study 31793041 — intervention group
Group type: EXPERIMENTAL
Intervention: ingenol mebutate gel (IMB)
Number of subjects: 0
Study 31793041 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac plus hyaluronate gel (DHA)
Number of subjects: 0
Study 29689257 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine (50 mg IV)
Number of subjects: 119
Study 29689257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 28453584 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured educative program
Number of subjects: 115
Study 28453584 — intervention group
Group type: COMPARATOR
Intervention: No structured education (control)
Number of subjects: 115
Study 24147575 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional protocol (T group)
Number of subjects: 50
Study 24147575 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified protocol (S group)
Number of subjects: 50
Study 23632672 — intervention group
Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia with peri-articular injection of bupivacaine, morphine, and methylprednisolone.
Number of subjects: 90
Study 23632672 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia (PCEA) plus femoral nerve blockade with bupivacaine nerve block and bupivacaine/hydromorphone PCEA.
Number of subjects: 90
Study 21099647 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery intervention (listened to a guided imagery CD)
Number of subjects: 121
Study 21099647 — intervention group
Group type: COMPARATOR
Intervention: Control group (no guided imagery intervention)
Number of subjects: 121
Study 19058099 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive alcohol sensor (PAS)
Number of subjects: 714
Study 19058099 — intervention group
Group type: COMPARATOR
Intervention: No passive alcohol sensor (Control group)
Number of subjects: 714
Study 16621186 — intervention group
Group type: EXPERIMENTAL
Intervention: Avaxim
Number of subjects: 120
Study 16621186 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaqta
Number of subjects: 120
Study 12859221 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential high dose chemotherapy (HDC) with granulocyte colony-stimulating factor (filgrastim) and stem cell support
Number of subjects: 95
Study 12859221 — intervention group
Group type: COMPARATOR
Intervention: Single course HDC with bone marrow transplantation (BMT)
Number of subjects: 95
Study 12859221 — intervention group
Group type: COMPARATOR
Intervention: Single course HDC with peripheral blood stem cell transplantation (PBSCT)
Number of subjects: 95
Study 11212135 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological counseling
Number of subjects: 15
Study 11212135 — intervention group
Group type: COMPARATOR
Intervention: Standard, non-specific supportive psychotherapy
Number of subjects: 15
Study 9001371 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (1.62 g/d)
Number of subjects: 24
Study 1309944 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous estradiol valerate (2 mg) plus cyproterone acetate (1 mg)
Number of subjects: 62
Study 1309944 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential estradiol valerate (2 mg) plus levonorgestrel (75 micrograms)
Number of subjects: 62
Study 1309944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 6734703 — intervention group
Group type: EXPERIMENTAL
Intervention: Theolin Retard 300 mg (sustained release tablet)
Number of subjects: 10
Study 6734703 — intervention group
Group type: COMPARATOR
Intervention: Intravenous aminophylline (reference material)
Number of subjects: 10
Study 30955455 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg.kg-1 caffeine (CAF3)
Number of subjects: 14
Study 30955455 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg.kg-1 caffeine (CAF6)
Number of subjects: 14
Study 30955455 — intervention group
Group type: COMPARATOR
Intervention: No substance (Control - CON)
Number of subjects: 14
Study 30328899 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (E)
Number of subjects: 20
Study 30328899 — intervention group
Group type: COMPARATOR
Intervention: Non-ethanol (N)
Number of subjects: 20
Study 30328899 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch-and-rinse (Er) with ethanol (E)
Number of subjects: 20
Study 30328899 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-etching (S) with non-ethanol (N)
Number of subjects: 20
Study 30328899 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged groups (A) with ethanol (E)
Number of subjects: 20
Study 30328899 — intervention group
Group type: COMPARATOR
Intervention: Non-aged groups (Na) with non-ethanol (N)
Number of subjects: 20
Study 27293053 — intervention group
Group type: COMPARATOR
Intervention: Single intramuscular injection of bone marrow mononuclear cells (n = 11)
Number of subjects: 22
Study 27293053 — intervention group
Group type: EXPERIMENTAL
Intervention: Four intramuscular injections of bone marrow mononuclear cells (n = 11)
Number of subjects: 22
Study 27293053 — intervention group
Group type: EXPERIMENTAL
Intervention: Both single and four injections of bone marrow mononuclear cells
Number of subjects: 22
Study 24568487 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedaplatin (NDP)
Number of subjects: 619
Study 24568487 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (DDP)
Number of subjects: 619
Study 22408783 — intervention group
Group type: EXPERIMENTAL
Intervention: Tescera ATL (TATL)
Number of subjects: 54
Study 22408783 — intervention group
Group type: EXPERIMENTAL
Intervention: Aelite Aesthetic (AA)
Number of subjects: 54
Study 22408783 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetric EvoCeram (TEC)
Number of subjects: 54
Study 22408783 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Supreme XT (FS)
Number of subjects: 54
Study 22408783 — intervention group
Group type: EXPERIMENTAL
Intervention: Estenia (E)
Number of subjects: 54
Study 19576318 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide plus a heparin product
Number of subjects: 857
Study 19576318 — intervention group
Group type: COMPARATOR
Intervention: Bivalirudin monotherapy
Number of subjects: 857
Study 19576318 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemia duration
Number of subjects: 857
Study 19576318 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic events within the first 4 hours after PCI
Number of subjects: 857
Study 18277670 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g in 250 ml normal saline, infused before tourniquet deflation and again 3 hours later)
Number of subjects: 102
Study 18277670 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (250 ml infused intravenously)
Number of subjects: 102
Study 18277670 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 102
Study 18277670 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 102
Study 18277670 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid and Normal saline
Number of subjects: 102
Study 15277964 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation (physical and occupational therapy sessions five times per week for 24.8 +/- 8.1 days)
Number of subjects: 30
Study 12195325 — intervention group
Group type: EXPERIMENTAL
Intervention: Transjugular intrahepatic portosystemic stent shunt (TIPS)
Number of subjects: 85
Study 12195325 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic variceal ligation (EVL) plus propranolol
Number of subjects: 85
Study 9807208 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive preoperative radiotherapy (IPRT)
Number of subjects: 423
Study 9807208 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive preoperative radiotherapy (IPRT) combined with postoperative chemo- and hormonal therapy
Number of subjects: 423
Study 7815697 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous interpleural infusion of 0.5% bupivacaine at the rate of 5 ml.h‐1
Number of subjects: 20
Study 7815697 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural infusion of 0.25% bupivacaine and 0.025 buprenorphine at the rate of 1 ml.h‐1
Number of subjects: 20
Study 2767930 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated and teacher-rated questionnaires
Number of subjects: 0
Study 31988195 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression
Number of subjects: 0
Study 31988195 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple linear regression
Number of subjects: 0
Study 31988195 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox regression
Number of subjects: 0
Study 31112383 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium continuous infusion (median duration 47.8 hours, median dose 1807 mg) with deep sedation
Number of subjects: 1006
Study 31112383 — intervention group
Group type: COMPARATOR
Intervention: Usual-care approach without routine neuromuscular blockade and lighter sedation targets
Number of subjects: 1006
Study 31112383 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium continuous infusion
Number of subjects: 1006
Study 31112383 — intervention group
Group type: COMPARATOR
Intervention: Usual-care approach
Number of subjects: 1006
Study 28492492 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein supplement (PRO)
Number of subjects: 84
Study 28492492 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin supplement (CHO)
Number of subjects: 84
Study 26110548 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Constant Score (CS)
Number of subjects: 126
Study 26110548 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxford Shoulder Score (OSS)
Number of subjects: 126
Study 26110548 — intervention group
Group type: EXPERIMENTAL
Intervention: European Quality of Life‐5 Dimensions‐3 Level (EQ‐5D‐3L) index
Number of subjects: 126
Study 23375006 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR
Number of subjects: 58
Study 23375006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 21967071 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 20 mg/day
Number of subjects: 270
Study 21967071 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalmefene 80 mg/day
Number of subjects: 270
Study 21967071 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg on day 7
Number of subjects: 270
Study 21967071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1 g x two times daily
Number of subjects: 950
Study 19267709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir before bedtime
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 30 before dinner
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin aspart before main meals and insulin detemir before bedtime
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite outcome of death, acute myocardial infarction, stroke or amputation
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Average postprandial glucose increment from 0 to 18 months
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycaemia and any inadvertent medical episodes
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in plaque formation in the carotids
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular biomarkers
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Body composition
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression of microvascular complications
Number of subjects: 950
Study 19267709 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 950
Study 16451151 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified reliable change index
Number of subjects: 204
Study 16451151 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% decline on 20% of tasks rule
Number of subjects: 204
Study 16451151 — intervention group
Group type: EXPERIMENTAL
Intervention: 1SD decline on two or more tasks
Number of subjects: 204
Study 16451151 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy non-surgical controls)
Number of subjects: 204
Study 15491720 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 10 mg
Number of subjects: 887
Study 15491720 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 887
Study 15491720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 887
Study 11730741 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase support with vaginal progesterone beginning on day 3 after oocyte retrieval
Number of subjects: 126
Study 11730741 — intervention group
Group type: COMPARATOR
Intervention: Luteal phase support with vaginal progesterone beginning on day 6 after oocyte retrieval
Number of subjects: 126
Study 11730741 — intervention group
Group type: COMPARATOR
Intervention: Luteal phase support with vaginal progesterone beginning on day 6 after oocyte retrieval (GnRH agonist group)
Number of subjects: 126
Study 11730741 — intervention group
Group type: EXPERIMENTAL
Intervention: Luteal phase support with vaginal progesterone beginning on day 3 after oocyte retrieval (GnRH agonist group)
Number of subjects: 126
Study 9203450 — intervention group
Group type: EXPERIMENTAL
Intervention: EM523L
Number of subjects: 6
Study 9203450 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 6
Study 8382120 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic factor (ANF) 2.5 pmol/kg/min for 120 minutes
Number of subjects: 20
Study 8382120 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle alone)
Number of subjects: 20
Study 3303278 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aerosol 400 micrograms once daily
Number of subjects: 41
Study 3303278 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate aerosol 200 micrograms twice daily
Number of subjects: 41
Study 3303278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 31691579 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothermically stored amniotic membrane (HSAM)
Number of subjects: 76
Study 31691579 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 76
Study 30285718 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation facilitation strategy (external facilitation plus QI team)
Number of subjects: 12
Study 30285718 — intervention group
Group type: COMPARATOR
Intervention: Standard VA national support
Number of subjects: 12
Study 27588541 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-congruent stimuli in a pub context
Number of subjects: 76
Study 27588541 — intervention group
Group type: COMPARATOR
Intervention: Alcohol-incongruent stimuli in a lecture context
Number of subjects: 76
Study 24897738 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps-sparing (QS) technique
Number of subjects: 129
Study 24897738 — intervention group
Group type: COMPARATOR
Intervention: Medial parapatellar arthrotomy (MPPA) technique
Number of subjects: 129
Study 22882572 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day discharge with remote monitoring for 24 hours after ICD implant
Number of subjects: 71
Study 22882572 — intervention group
Group type: COMPARATOR
Intervention: Next-day discharge with overnight in-hospital observation
Number of subjects: 71
Study 21143399 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% homatropine eye drops
Number of subjects: 40
Study 21143399 — intervention group
Group type: COMPARATOR
Intervention: 0.5% hypromellose (placebo) eye drops
Number of subjects: 40
Study 18666018 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelfoam embolization
Number of subjects: 54
Study 18666018 — intervention group
Group type: COMPARATOR
Intervention: Traditional particle embolization
Number of subjects: 54
Study 16075570 — intervention group
Group type: EXPERIMENTAL
Intervention: School breakfast program (supplemented children)
Number of subjects: 540
Study 16075570 — intervention group
Group type: EXPERIMENTAL
Intervention: School breakfast program with meat
Number of subjects: 540
Study 16075570 — intervention group
Group type: COMPARATOR
Intervention: Control group (children receiving a goat)
Number of subjects: 540
Study 12383667 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg daily for bodyweight ≤40 kg; 500 mg daily for bodyweight >40 kg)
Number of subjects: 41
Study 12383667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 12383667 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 41
Study 12383667 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin and Placebo
Number of subjects: 41
Study 12840867 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (Protheo, 400 mg, qd)
Number of subjects: 28
Study 12840867 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 8772970 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate 2 gm bolus
Number of subjects: 154
Study 8772970 — intervention group
Group type: COMPARATOR
Intervention: Intravenous verapamil 5 mg
Number of subjects: 154
Study 2383413 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific feedback
Number of subjects: 29
Study 2383413 — intervention group
Group type: COMPARATOR
Intervention: Reminder checklists
Number of subjects: 29
Study 2383413 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (checklists + feedback)
Number of subjects: 29
Study 2383413 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study 6259922 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid glucose formula (75 g carbohydrate)
Number of subjects: 8
Study 6259922 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown rice (75 g carbohydrate)
Number of subjects: 8
Study 6259922 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinto beans (75 g carbohydrate)
Number of subjects: 8
Study 6259922 — intervention group
Group type: EXPERIMENTAL
Intervention: All Bran (75 g carbohydrate)
Number of subjects: 8
Study 6259922 — intervention group
Group type: COMPARATOR
Intervention: Control (no dietary fiber)
Number of subjects: 8
Study 31653011 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement plus physical activity
Number of subjects: 0
Study 31653011 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and physical activity alone
Number of subjects: 0
Study 31653011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29132930 — intervention group
Group type: EXPERIMENTAL
Intervention: eCRTAF
Number of subjects: 0
Study 29132930 — intervention group
Group type: COMPARATOR
Intervention: Control (Conducted AF Response)
Number of subjects: 0
Study 27283295 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet smoking cessation intervention
Number of subjects: 5290
Study 27283295 — intervention group
Group type: COMPARATOR
Intervention: NHIS smokers (control group)
Number of subjects: 5290